AI assistant
Solid Biosciences Inc. — Director's Dealing 2025
Nov 13, 2025
33003_dirs_2025-11-13_e6f48841-9c60-4d1b-8f38-b4788b7223e9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2025-11-10
Reporting Person: Ganot Ilan (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-10 | Common Stock | S | 3278 | $4.12 | Disposed | 95412 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 14839 | Indirect |
| Common Stock | 19394 | Indirect |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.11 to $4.12, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form.
F2: Represents 91,370 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.
F3: Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.